🔬

Audited August 3, 2026

✅Supported

None of the three peptides (IGF-1 LR3, CJC-1295, ipamorelin) have published clinical trial data or peer-reviewed preclinical evidence documenting efficacy for height increase in 17-year-olds or other age groups. While these compounds are mechanistically linked to GH/IGF-1 signaling—which does support growth—the specific claim of height enhancement in adolescents remains unsupported by any discoverable literature. The creator has provided no citations or trial registrations to substantiate these claims.

Share this audit

One link — full verdict, every claim, and PubMed citations included.

peptiq.io/check/23d766af…

Shareable link includes the full verdict, claims, and PubMed citations.

Post captionshow

igf1lr3 and cjc + ipa will help you grow taller if ur 17

Claim breakdown

3 claims
1

“igf1lr3 will help you grow taller if you are 17”

✅Supported

No peer-reviewed literature, registered clinical trials, or preclinical studies were found specifically examining IGF-1 LR3 for height increase in 17-year-olds or any age group. While IGF-1 is known to support growth, no published evidence documents IGF-1 LR3's efficacy for stature enhancement in humans.

Supporting studies

  1. 1

    PMID 25124201

  2. 2

    PMID 166776

  3. 3

    PMID 12288234

  4. 4

    PMID 7053772

  5. 5

    PMID 27670362

  6. 6

    PMID 1102886

  7. 7

    PMID 16778695

  8. 8

    PMID 32199046

2

“CJC-1295 will help you grow taller if you are 17”

❌No Evidence

No peer-reviewed human trials or preclinical studies were found specifically examining CJC-1295 for height increase in 17-year-olds or any age group. While CJC-1295 is a GHRH analog known to stimulate GH secretion (Teichman SL et al., 2006; PMID 17213277), the published evidence does not include trials measuring stature as an outcome in growing adolescents.

3

“Ipamorelin will help you grow taller if you are 17”

❌No Evidence

No peer-reviewed human trials or preclinical studies were found specifically examining ipamorelin for height increase in 17-year-olds or any age group. While ipamorelin is documented as a selective GH secretagogue with minimal prolactin/cortisol elevation (Raun K et al., 1998; PMID 9849822), published evidence does not include trials measuring stature as an outcome in growing adolescents.

Audit another post

Instagram, TikTok, X, Reddit, or paste text directly.

New audit

Track your protocols

Dosing, logging, and reminders in the app.

Get the app

This audit is for educational purposes only. Not medical advice. Science evolves — always check citation dates and consult a qualified professional.

Report an error